Nomura Holdings Inc. increased its stake in Keurig Dr Pepper Inc. (NASDAQ:KDP - Free Report) by 17.1% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 102,739 shares of the company's stock after buying an additional 14,968 shares during the quarter. Nomura Holdings Inc.'s holdings in Keurig Dr Pepper were worth $3,300,000 as of its most recent filing with the SEC.
Other large investors have also modified their holdings of the company. NorthRock Partners LLC acquired a new stake in Keurig Dr Pepper during the 4th quarter valued at approximately $13,021,000. Nuveen Asset Management LLC grew its stake in Keurig Dr Pepper by 16.9% during the 4th quarter. Nuveen Asset Management LLC now owns 5,000,847 shares of the company's stock valued at $160,627,000 after purchasing an additional 721,908 shares in the last quarter. Numerai GP LLC acquired a new stake in Keurig Dr Pepper during the 4th quarter valued at approximately $923,000. OMERS ADMINISTRATION Corp grew its stake in Keurig Dr Pepper by 20.8% during the 4th quarter. OMERS ADMINISTRATION Corp now owns 45,703 shares of the company's stock valued at $1,468,000 after purchasing an additional 7,861 shares in the last quarter. Finally, Lazard Asset Management LLC grew its stake in Keurig Dr Pepper by 47.9% during the 4th quarter. Lazard Asset Management LLC now owns 505,362 shares of the company's stock valued at $16,231,000 after purchasing an additional 163,753 shares in the last quarter. Institutional investors and hedge funds own 93.99% of the company's stock.
Wall Street Analysts Forecast Growth
KDP has been the subject of several research reports. UBS Group lifted their target price on Keurig Dr Pepper from $40.00 to $42.00 and gave the stock a "buy" rating in a research report on Thursday, April 17th. Barclays lifted their target price on Keurig Dr Pepper from $37.00 to $38.00 and gave the stock an "overweight" rating in a research report on Monday, April 28th. Argus initiated coverage on Keurig Dr Pepper in a research report on Wednesday, April 16th. They issued a "buy" rating and a $40.00 target price for the company. JPMorgan Chase & Co. lifted their target price on Keurig Dr Pepper from $37.00 to $40.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 26th. Finally, Hsbc Global Res upgraded Keurig Dr Pepper from a "hold" rating to a "strong-buy" rating in a research report on Friday, April 25th. Four research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, Keurig Dr Pepper presently has an average rating of "Moderate Buy" and an average target price of $39.33.
Read Our Latest Stock Analysis on Keurig Dr Pepper
Keurig Dr Pepper Stock Performance
Keurig Dr Pepper stock traded up $0.01 during mid-day trading on Monday, hitting $33.83. 8,217,014 shares of the company's stock traded hands, compared to its average volume of 10,542,943. The company has a market cap of $45.95 billion, a PE ratio of 20.50, a price-to-earnings-growth ratio of 2.42 and a beta of 0.52. The company has a quick ratio of 0.36, a current ratio of 0.53 and a debt-to-equity ratio of 0.50. Keurig Dr Pepper Inc. has a one year low of $30.12 and a one year high of $38.28. The firm has a 50 day moving average price of $34.22 and a 200 day moving average price of $33.01.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last posted its quarterly earnings data on Thursday, April 24th. The company reported $0.42 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.04. The business had revenue of $3.64 billion during the quarter, compared to the consensus estimate of $3.57 billion. Keurig Dr Pepper had a net margin of 15.04% and a return on equity of 10.45%. The company's quarterly revenue was up 4.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.38 earnings per share. On average, equities analysts forecast that Keurig Dr Pepper Inc. will post 1.92 EPS for the current year.
Insider Transactions at Keurig Dr Pepper
In other news, major shareholder Bevco B.V. Jab sold 83,950,000 shares of the firm's stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $32.65, for a total value of $2,740,967,500.00. Following the completion of the sale, the insider now owns 134,113,479 shares of the company's stock, valued at $4,378,805,089.35. This trade represents a 38.50% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, VP Angela A. Stephens sold 7,350 shares of the firm's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $34.17, for a total value of $251,149.50. Following the completion of the sale, the vice president now directly owns 74,587 shares of the company's stock, valued at approximately $2,548,637.79. This trade represents a 8.97% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 84,863,850 shares of company stock valued at $2,772,203,450. Company insiders own 0.40% of the company's stock.
Keurig Dr Pepper Profile
(
Free Report)
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
See Also

Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.